Entering text into the input field will update the search result below

Premarket analyst action - healthcare

Jan. 16, 2018 9:04 AM ETNovo Nordisk A/S (NVO) StockGILD, RHHBY, NVO, LLY, MOH, IDXX, MDRX, tig-oldBy: Douglas W. House, SA News Editor2 Comments
  • Dicerna Pharmaceuticals (NASDAQ:DRNA) initiated with Outperform rating and $14 (66% upside) price target by Evercore ISI.
  • IDEXX Labs (NASDAQ:IDXX) initiated with Overweight rating and $200 (15% upside) price target by Piper Jaffray.
  • Molina Healthcare (NYSE:MOH) upgraded to Overweight by JPMorgan.
  • Gilead Sciences (NASDAQ:GILD) upgraded to Outperform by Wells Fargo.
  • Spark Therapeutics (NASDAQ:ONCE) downgraded to Underperform with a price target of $35 (34% downside risk) by Wedbush. Shares are down 5% premarket on light volume.
  • TiGenix (NASDAQ:TIG) downgraded to Neutral by BTIG Research.
  • Allscripts Healthcare (NASDAQ:MDRX) downgraded to Hold by SunTrust.
  • Eli Lilly (NYSE:LLY) downgraded to Neutral by Goldman Sachs.

Recommended For You

About NVO Stock

SymbolLast Price% Chg
Market Cap
PE
Yield (TTM)
Rev Growth (YoY)
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
NVO--
Novo Nordisk A/S